ADUS

ADUS

USD

Addus HomeCare Corporation Common Stock

$105.000-0.060 (-0.057%)

Reaalajas hind

Healthcare
Medical Care Facilities
Ameerika Ühendriigid

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika

Turunäitajad

Avatud

$105.060

Kõrge

$106.180

Madal

$103.445

Maht

0.03M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

1.9B

Tööstusharu

Medical Care Facilities

Riik

United States

Kauplemisstatistika

Keskmine maht

0.23M

Börs

NMS

Valuuta

USD

52 nädala vahemik

Madal $88.96Praegune $105.000Kõrge $136.72

Tehisintellekti analüüsiaruanne

Viimati uuendatud: 29. apr 2025
Tehisintellekti loodudAndmeallikas: Yahoo Finance, Bloomberg, SEC

ADUS: Addus HomeCare Corporation Common Stock - Analyzing Recent Moves & What Might Come Next

Stock Symbol: ADUS Generate Date: 2025-04-29 19:03:21

Alright, let's break down what's been happening with Addus HomeCare stock lately and what the tea leaves might be suggesting. We'll look at the recent news, check out the price chart, and see what the AI model is thinking.

What's the Buzz? (News Sentiment)

Recent news for ADUS seems pretty positive, mainly thanks to analysts. We saw JMP Securities analysts, first Constantine Davides and then Nicholas Jones, both come out and reiterate their "Market Outperform" rating on the stock. That's basically Wall Street speak for "we think this stock is going to do better than the average market." On top of that, they're sticking with a pretty ambitious price target of $150. Considering where the stock is trading now, that's a significant jump if it were to happen.

The other big piece of news is simply an announcement: Addus HomeCare is planning to release its first-quarter earnings report on May 5th, after the market closes. This is a really important date because it's when we'll get the actual numbers on how the company performed. Analyst opinions are one thing, but the earnings report shows the real business results. So, while the analyst sentiment is upbeat, everyone is likely waiting to see those Q1 figures.

Checking the Price Chart (Price Action)

Looking back at the stock's journey over the past few months, it's been quite a ride. The price started the year much higher, up around $130, but then took a significant dip through February and early March, hitting a low point near $89. Since then, though, it's been steadily climbing back up.

Right now, the stock is trading around the $101-$103 mark. This is a nice recovery from those March lows, but still a long way off from where it started the year or that $150 analyst target.

Interestingly, the AI prediction model is also seeing some potential for short-term upward movement. It's forecasting positive percentage changes for today and the next couple of days.

Putting It Together: Outlook & Some Ideas

So, what does all this suggest? Based on the positive analyst ratings, the recent upward trend in the stock price, and the AI's short-term forecast, the immediate picture seems to lean a bit positive. Analysts are bullish, the price is recovering, and the AI sees more potential upside right now.

However, that upcoming earnings report on May 5th is a major event. Good earnings could fuel the recovery and maybe even push it closer to those analyst targets. Bad earnings, on the other hand, could easily reverse the recent gains.

If someone were considering getting involved based on this data, the current price area, roughly $101-$103, might be looked at, especially since the AI predicts short-term gains from here and the recommendation data points to entry levels very close by ($100.31, $100.95).

For managing risk, the recommendation data offers some potential levels to think about. A stop-loss around $90.94 could be considered; this is below the recent significant lows and acts as a potential exit point if the recovery falters badly. On the upside, a potential take-profit level is suggested around $107.62. This is above the current price and aligns with the idea of capturing some of the recent momentum, though it's well below the analyst's long-term target. Remember, these are just potential levels based on the data provided, not guarantees.

A Little Company Context

It's helpful to remember that Addus HomeCare is in the healthcare sector, specifically providing home care services like personal care, hospice, and home health. This means their business performance is tied to factors like healthcare policies, demographics (an aging population often increases demand for these services), and their ability to manage costs and staffing. The analyst ratings and the upcoming earnings report are important because they give us a look into how the company is navigating these specific industry dynamics.


Disclaimer: This analysis is based solely on the provided data and is for informational purposes only. It is not financial advice. Stock markets are volatile, and prices can go down as well as up. You should always conduct your own thorough research and consider consulting with a qualified financial advisor before making any investment decisions.

Seotud uudised

Analyst Upgrades

JMP Securities Reiterates Market Outperform on Addus HomeCare, Maintains $150 Price Target

JMP Securities analyst Nicholas Jones reiterates Addus HomeCare with a Market Outperform and maintains $150 price target.

Vaata rohkem
JMP Securities Reiterates Market Outperform on Addus HomeCare, Maintains $150 Price Target
BusinessWire

Addus HomeCare Announces First Quarter 2025 Earnings Release and Conference Call

Addus HomeCare Corporation (NASDAQ:ADUS), a provider of home care services, announced today that it will release earnings for the first quarter ended March 31, 2025, on Monday, May 5, 2025, after the market

Vaata rohkem
Addus HomeCare Announces First Quarter 2025 Earnings Release and Conference Call
Analyst Upgrades

JMP Securities Maintains Market Outperform on Addus HomeCare, Maintains $150 Price Target

JMP Securities analyst Constantine Davides maintains Addus HomeCare with a Market Outperform and maintains $150 price target.

Vaata rohkem
JMP Securities Maintains Market Outperform on Addus HomeCare, Maintains $150 Price Target

Tehisintellekti ennustusBeta

Tehisintellekti soovitus

Tõusev

Uuendatud kell: 4. mai 2025, 00:56

LangevNeutraalneTõusev

62.7% Kindlus

Risk ja kauplemine

Riskitase3/5
Keskmine risk
Sobib
Mõõdukas
Kauplemisjuhend

Sisenemispunkt

$105.40

Võta kasum

$107.09

Peata kahjum

$94.49

Põhitegurid

DMI näitab langustrendi (ADX:11.0, +DI:14.2, -DI:16.4), mis viitab ettevaatlikkusele
Praegune hind on tugitasemele ($105.39) äärmiselt lähedal, mis viitab tugevale ostuvõimalusele
Kauplemismaht on 5.5x keskmisest (2,947), mis viitab äärmiselt tugevale ostusurvele
MACD 0.1047 on signaalijoone 0.1455 all, mis viitab langevale ristumisele

Püsi kursis

Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.